0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trihexyphenidyl Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-16S19134
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Trihexyphenidyl Drug Market Research Report 2025
BUY CHAPTERS

Global Trihexyphenidyl Drug Market Research Report 2025

Code: QYRE-Auto-16S19134
Report
March 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Trihexyphenidyl Drug Market Size

The global market for Trihexyphenidyl Drug was valued at US$ 64.8 million in the year 2024 and is projected to reach a revised size of US$ 81.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Trihexyphenidyl Drug Market

Trihexyphenidyl Drug Market

Trihexyphenidyl Drug for Parkinson’s disease (PD) are medications that block the action of acetylcholine in the brain to help balance the neurotransmitter activity disrupted by dopamine deficiency. These drugs are primarily used to control tremors and muscle stiffness in Parkinson’s patients, particularly in the early stages of the disease. By inhibiting excessive cholinergic activity, anticholinergic agents can provide symptomatic relief and improve motor function. Common anticholinergic drugs for PD include benztropine and trihexyphenidyl.Benzhexol Hydrochloride, also known as Trihexyphenidyl, is an anticholinergic drug primarily used to treat Parkinson’s disease and drug-induced extrapyramidal symptoms. It works by blocking acetylcholine receptors in the central nervous system, helping to restore the balance between dopamine and acetylcholine, which is disrupted in Parkinson’s disease. This mechanism helps reduce symptoms such as muscle stiffness, tremors, and involuntary movements, improving motor function in affected patients.
North American market for Trihexyphenidyl Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Trihexyphenidyl Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Trihexyphenidyl Drug include Kangpu Pharma, Pfizer, TASLY DIYI Pharma, Zhongnan Pharma, Sun Pharmaceutical, Biogalenic, Eisai Co Ltd, Grindex, Novitium Pharma, TEOFARMA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Trihexyphenidyl Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trihexyphenidyl Drug.
The Trihexyphenidyl Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trihexyphenidyl Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trihexyphenidyl Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Trihexyphenidyl Drug Market Report

Report Metric Details
Report Name Trihexyphenidyl Drug Market
Accounted market size in year US$ 64.8 million
Forecasted market size in 2031 US$ 81.7 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Syrup
  • Tablets
  • Sustained-release Capsules
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kangpu Pharma, Pfizer, TASLY DIYI Pharma, Zhongnan Pharma, Sun Pharmaceutical, Biogalenic, Eisai Co Ltd, Grindex, Novitium Pharma, TEOFARMA, Nichiiko, Sanofi, Teva, Apsen Farmaceutica, Intas Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Trihexyphenidyl Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Trihexyphenidyl Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Trihexyphenidyl Drug Market growing?

Ans: The Trihexyphenidyl Drug Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Trihexyphenidyl Drug Market size in 2031?

Ans: The Trihexyphenidyl Drug Market size in 2031 will be US$ 81.7 million.

Who are the main players in the Trihexyphenidyl Drug Market report?

Ans: The main players in the Trihexyphenidyl Drug Market are Kangpu Pharma, Pfizer, TASLY DIYI Pharma, Zhongnan Pharma, Sun Pharmaceutical, Biogalenic, Eisai Co Ltd, Grindex, Novitium Pharma, TEOFARMA, Nichiiko, Sanofi, Teva, Apsen Farmaceutica, Intas Pharmaceuticals

What are the Application segmentation covered in the Trihexyphenidyl Drug Market report?

Ans: The Applications covered in the Trihexyphenidyl Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Trihexyphenidyl Drug Market report?

Ans: The Types covered in the Trihexyphenidyl Drug Market report are Syrup, Tablets, Sustained-release Capsules

1 Trihexyphenidyl Drug Market Overview
1.1 Product Definition
1.2 Trihexyphenidyl Drug by Type
1.2.1 Global Trihexyphenidyl Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Syrup
1.2.3 Tablets
1.2.4 Sustained-release Capsules
1.3 Trihexyphenidyl Drug by Application
1.3.1 Global Trihexyphenidyl Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Trihexyphenidyl Drug Market Size Estimates and Forecasts
1.4.1 Global Trihexyphenidyl Drug Revenue 2020-2031
1.4.2 Global Trihexyphenidyl Drug Sales 2020-2031
1.4.3 Global Trihexyphenidyl Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Trihexyphenidyl Drug Market Competition by Manufacturers
2.1 Global Trihexyphenidyl Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Trihexyphenidyl Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Trihexyphenidyl Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Trihexyphenidyl Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Trihexyphenidyl Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trihexyphenidyl Drug, Product Type & Application
2.7 Global Key Manufacturers of Trihexyphenidyl Drug, Date of Enter into This Industry
2.8 Global Trihexyphenidyl Drug Market Competitive Situation and Trends
2.8.1 Global Trihexyphenidyl Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Trihexyphenidyl Drug Players Market Share by Revenue
2.8.3 Global Trihexyphenidyl Drug Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Trihexyphenidyl Drug Market Scenario by Region
3.1 Global Trihexyphenidyl Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Trihexyphenidyl Drug Sales by Region: 2020-2031
3.2.1 Global Trihexyphenidyl Drug Sales by Region: 2020-2025
3.2.2 Global Trihexyphenidyl Drug Sales by Region: 2026-2031
3.3 Global Trihexyphenidyl Drug Revenue by Region: 2020-2031
3.3.1 Global Trihexyphenidyl Drug Revenue by Region: 2020-2025
3.3.2 Global Trihexyphenidyl Drug Revenue by Region: 2026-2031
3.4 North America Trihexyphenidyl Drug Market Facts & Figures by Country
3.4.1 North America Trihexyphenidyl Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Trihexyphenidyl Drug Sales by Country (2020-2031)
3.4.3 North America Trihexyphenidyl Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trihexyphenidyl Drug Market Facts & Figures by Country
3.5.1 Europe Trihexyphenidyl Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Trihexyphenidyl Drug Sales by Country (2020-2031)
3.5.3 Europe Trihexyphenidyl Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trihexyphenidyl Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Trihexyphenidyl Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Trihexyphenidyl Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Trihexyphenidyl Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Trihexyphenidyl Drug Market Facts & Figures by Country
3.7.1 Latin America Trihexyphenidyl Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Trihexyphenidyl Drug Sales by Country (2020-2031)
3.7.3 Latin America Trihexyphenidyl Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Trihexyphenidyl Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Trihexyphenidyl Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Trihexyphenidyl Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Trihexyphenidyl Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trihexyphenidyl Drug Sales by Type (2020-2031)
4.1.1 Global Trihexyphenidyl Drug Sales by Type (2020-2025)
4.1.2 Global Trihexyphenidyl Drug Sales by Type (2026-2031)
4.1.3 Global Trihexyphenidyl Drug Sales Market Share by Type (2020-2031)
4.2 Global Trihexyphenidyl Drug Revenue by Type (2020-2031)
4.2.1 Global Trihexyphenidyl Drug Revenue by Type (2020-2025)
4.2.2 Global Trihexyphenidyl Drug Revenue by Type (2026-2031)
4.2.3 Global Trihexyphenidyl Drug Revenue Market Share by Type (2020-2031)
4.3 Global Trihexyphenidyl Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Trihexyphenidyl Drug Sales by Application (2020-2031)
5.1.1 Global Trihexyphenidyl Drug Sales by Application (2020-2025)
5.1.2 Global Trihexyphenidyl Drug Sales by Application (2026-2031)
5.1.3 Global Trihexyphenidyl Drug Sales Market Share by Application (2020-2031)
5.2 Global Trihexyphenidyl Drug Revenue by Application (2020-2031)
5.2.1 Global Trihexyphenidyl Drug Revenue by Application (2020-2025)
5.2.2 Global Trihexyphenidyl Drug Revenue by Application (2026-2031)
5.2.3 Global Trihexyphenidyl Drug Revenue Market Share by Application (2020-2031)
5.3 Global Trihexyphenidyl Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kangpu Pharma
6.1.1 Kangpu Pharma Company Information
6.1.2 Kangpu Pharma Description and Business Overview
6.1.3 Kangpu Pharma Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kangpu Pharma Trihexyphenidyl Drug Product Portfolio
6.1.5 Kangpu Pharma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Trihexyphenidyl Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 TASLY DIYI Pharma
6.3.1 TASLY DIYI Pharma Company Information
6.3.2 TASLY DIYI Pharma Description and Business Overview
6.3.3 TASLY DIYI Pharma Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TASLY DIYI Pharma Trihexyphenidyl Drug Product Portfolio
6.3.5 TASLY DIYI Pharma Recent Developments/Updates
6.4 Zhongnan Pharma
6.4.1 Zhongnan Pharma Company Information
6.4.2 Zhongnan Pharma Description and Business Overview
6.4.3 Zhongnan Pharma Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zhongnan Pharma Trihexyphenidyl Drug Product Portfolio
6.4.5 Zhongnan Pharma Recent Developments/Updates
6.5 Sun Pharmaceutical
6.5.1 Sun Pharmaceutical Company Information
6.5.2 Sun Pharmaceutical Description and Business Overview
6.5.3 Sun Pharmaceutical Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharmaceutical Trihexyphenidyl Drug Product Portfolio
6.5.5 Sun Pharmaceutical Recent Developments/Updates
6.6 Biogalenic
6.6.1 Biogalenic Company Information
6.6.2 Biogalenic Description and Business Overview
6.6.3 Biogalenic Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biogalenic Trihexyphenidyl Drug Product Portfolio
6.6.5 Biogalenic Recent Developments/Updates
6.7 Eisai Co Ltd
6.7.1 Eisai Co Ltd Company Information
6.7.2 Eisai Co Ltd Description and Business Overview
6.7.3 Eisai Co Ltd Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eisai Co Ltd Trihexyphenidyl Drug Product Portfolio
6.7.5 Eisai Co Ltd Recent Developments/Updates
6.8 Grindex
6.8.1 Grindex Company Information
6.8.2 Grindex Description and Business Overview
6.8.3 Grindex Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Grindex Trihexyphenidyl Drug Product Portfolio
6.8.5 Grindex Recent Developments/Updates
6.9 Novitium Pharma
6.9.1 Novitium Pharma Company Information
6.9.2 Novitium Pharma Description and Business Overview
6.9.3 Novitium Pharma Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Novitium Pharma Trihexyphenidyl Drug Product Portfolio
6.9.5 Novitium Pharma Recent Developments/Updates
6.10 TEOFARMA
6.10.1 TEOFARMA Company Information
6.10.2 TEOFARMA Description and Business Overview
6.10.3 TEOFARMA Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 TEOFARMA Trihexyphenidyl Drug Product Portfolio
6.10.5 TEOFARMA Recent Developments/Updates
6.11 Nichiiko
6.11.1 Nichiiko Company Information
6.11.2 Nichiiko Description and Business Overview
6.11.3 Nichiiko Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nichiiko Trihexyphenidyl Drug Product Portfolio
6.11.5 Nichiiko Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Company Information
6.12.2 Sanofi Description and Business Overview
6.12.3 Sanofi Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi Trihexyphenidyl Drug Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
6.13 Teva
6.13.1 Teva Company Information
6.13.2 Teva Description and Business Overview
6.13.3 Teva Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Trihexyphenidyl Drug Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Apsen Farmaceutica
6.14.1 Apsen Farmaceutica Company Information
6.14.2 Apsen Farmaceutica Description and Business Overview
6.14.3 Apsen Farmaceutica Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Apsen Farmaceutica Trihexyphenidyl Drug Product Portfolio
6.14.5 Apsen Farmaceutica Recent Developments/Updates
6.15 Intas Pharmaceuticals
6.15.1 Intas Pharmaceuticals Company Information
6.15.2 Intas Pharmaceuticals Description and Business Overview
6.15.3 Intas Pharmaceuticals Trihexyphenidyl Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Intas Pharmaceuticals Trihexyphenidyl Drug Product Portfolio
6.15.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trihexyphenidyl Drug Industry Chain Analysis
7.2 Trihexyphenidyl Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trihexyphenidyl Drug Production Mode & Process Analysis
7.4 Trihexyphenidyl Drug Sales and Marketing
7.4.1 Trihexyphenidyl Drug Sales Channels
7.4.2 Trihexyphenidyl Drug Distributors
7.5 Trihexyphenidyl Drug Customer Analysis
8 Trihexyphenidyl Drug Market Dynamics
8.1 Trihexyphenidyl Drug Industry Trends
8.2 Trihexyphenidyl Drug Market Drivers
8.3 Trihexyphenidyl Drug Market Challenges
8.4 Trihexyphenidyl Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Trihexyphenidyl Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Trihexyphenidyl Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Trihexyphenidyl Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Trihexyphenidyl Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Trihexyphenidyl Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Trihexyphenidyl Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Trihexyphenidyl Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Trihexyphenidyl Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Trihexyphenidyl Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Trihexyphenidyl Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Trihexyphenidyl Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Trihexyphenidyl Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Trihexyphenidyl Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trihexyphenidyl Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Trihexyphenidyl Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Trihexyphenidyl Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Trihexyphenidyl Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Trihexyphenidyl Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Trihexyphenidyl Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Trihexyphenidyl Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Trihexyphenidyl Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Trihexyphenidyl Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Trihexyphenidyl Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Trihexyphenidyl Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Trihexyphenidyl Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Trihexyphenidyl Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Trihexyphenidyl Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Trihexyphenidyl Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Trihexyphenidyl Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Trihexyphenidyl Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Trihexyphenidyl Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Trihexyphenidyl Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Trihexyphenidyl Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Trihexyphenidyl Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Trihexyphenidyl Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Trihexyphenidyl Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Trihexyphenidyl Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Trihexyphenidyl Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Trihexyphenidyl Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Trihexyphenidyl Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Trihexyphenidyl Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Trihexyphenidyl Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Trihexyphenidyl Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Trihexyphenidyl Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Trihexyphenidyl Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Trihexyphenidyl Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Trihexyphenidyl Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Trihexyphenidyl Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Trihexyphenidyl Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Trihexyphenidyl Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Trihexyphenidyl Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Trihexyphenidyl Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Trihexyphenidyl Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Trihexyphenidyl Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Trihexyphenidyl Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Trihexyphenidyl Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Trihexyphenidyl Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Trihexyphenidyl Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Trihexyphenidyl Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Trihexyphenidyl Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Trihexyphenidyl Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Trihexyphenidyl Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Trihexyphenidyl Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Trihexyphenidyl Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Trihexyphenidyl Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Trihexyphenidyl Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Trihexyphenidyl Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Trihexyphenidyl Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Kangpu Pharma Company Information
 Table 71. Kangpu Pharma Description and Business Overview
 Table 72. Kangpu Pharma Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Kangpu Pharma Trihexyphenidyl Drug Product
 Table 74. Kangpu Pharma Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Trihexyphenidyl Drug Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. TASLY DIYI Pharma Company Information
 Table 81. TASLY DIYI Pharma Description and Business Overview
 Table 82. TASLY DIYI Pharma Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TASLY DIYI Pharma Trihexyphenidyl Drug Product
 Table 84. TASLY DIYI Pharma Recent Developments/Updates
 Table 85. Zhongnan Pharma Company Information
 Table 86. Zhongnan Pharma Description and Business Overview
 Table 87. Zhongnan Pharma Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Zhongnan Pharma Trihexyphenidyl Drug Product
 Table 89. Zhongnan Pharma Recent Developments/Updates
 Table 90. Sun Pharmaceutical Company Information
 Table 91. Sun Pharmaceutical Description and Business Overview
 Table 92. Sun Pharmaceutical Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sun Pharmaceutical Trihexyphenidyl Drug Product
 Table 94. Sun Pharmaceutical Recent Developments/Updates
 Table 95. Biogalenic Company Information
 Table 96. Biogalenic Description and Business Overview
 Table 97. Biogalenic Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Biogalenic Trihexyphenidyl Drug Product
 Table 99. Biogalenic Recent Developments/Updates
 Table 100. Eisai Co Ltd Company Information
 Table 101. Eisai Co Ltd Description and Business Overview
 Table 102. Eisai Co Ltd Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Eisai Co Ltd Trihexyphenidyl Drug Product
 Table 104. Eisai Co Ltd Recent Developments/Updates
 Table 105. Grindex Company Information
 Table 106. Grindex Description and Business Overview
 Table 107. Grindex Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Grindex Trihexyphenidyl Drug Product
 Table 109. Grindex Recent Developments/Updates
 Table 110. Novitium Pharma Company Information
 Table 111. Novitium Pharma Description and Business Overview
 Table 112. Novitium Pharma Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Novitium Pharma Trihexyphenidyl Drug Product
 Table 114. Novitium Pharma Recent Developments/Updates
 Table 115. TEOFARMA Company Information
 Table 116. TEOFARMA Description and Business Overview
 Table 117. TEOFARMA Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. TEOFARMA Trihexyphenidyl Drug Product
 Table 119. TEOFARMA Recent Developments/Updates
 Table 120. Nichiiko Company Information
 Table 121. Nichiiko Description and Business Overview
 Table 122. Nichiiko Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Nichiiko Trihexyphenidyl Drug Product
 Table 124. Nichiiko Recent Developments/Updates
 Table 125. Sanofi Company Information
 Table 126. Sanofi Description and Business Overview
 Table 127. Sanofi Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi Trihexyphenidyl Drug Product
 Table 129. Sanofi Recent Developments/Updates
 Table 130. Teva Company Information
 Table 131. Teva Description and Business Overview
 Table 132. Teva Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Teva Trihexyphenidyl Drug Product
 Table 134. Teva Recent Developments/Updates
 Table 135. Apsen Farmaceutica Company Information
 Table 136. Apsen Farmaceutica Description and Business Overview
 Table 137. Apsen Farmaceutica Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Apsen Farmaceutica Trihexyphenidyl Drug Product
 Table 139. Apsen Farmaceutica Recent Developments/Updates
 Table 140. Intas Pharmaceuticals Company Information
 Table 141. Intas Pharmaceuticals Description and Business Overview
 Table 142. Intas Pharmaceuticals Trihexyphenidyl Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Intas Pharmaceuticals Trihexyphenidyl Drug Product
 Table 144. Intas Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Trihexyphenidyl Drug Distributors List
 Table 148. Trihexyphenidyl Drug Customers List
 Table 149. Trihexyphenidyl Drug Market Trends
 Table 150. Trihexyphenidyl Drug Market Drivers
 Table 151. Trihexyphenidyl Drug Market Challenges
 Table 152. Trihexyphenidyl Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Trihexyphenidyl Drug
 Figure 2. Global Trihexyphenidyl Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Trihexyphenidyl Drug Market Share by Type: 2024 & 2031
 Figure 4. Syrup Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Sustained-release Capsules Product Picture
 Figure 7. Global Trihexyphenidyl Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Trihexyphenidyl Drug Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Other
 Figure 12. Global Trihexyphenidyl Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Trihexyphenidyl Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Trihexyphenidyl Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Trihexyphenidyl Drug Average Price (US$/Unit) & (2020-2031)
 Figure 16. Trihexyphenidyl Drug Report Years Considered
 Figure 17. Trihexyphenidyl Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Trihexyphenidyl Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Trihexyphenidyl Drug Players: Market Share by Revenue in Trihexyphenidyl Drug in 2024
 Figure 20. Trihexyphenidyl Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Trihexyphenidyl Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Trihexyphenidyl Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Trihexyphenidyl Drug Revenue Market Share by Country (2020-2031)
 Figure 24. United States Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Trihexyphenidyl Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Trihexyphenidyl Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Trihexyphenidyl Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Trihexyphenidyl Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Trihexyphenidyl Drug Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Trihexyphenidyl Drug Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Trihexyphenidyl Drug Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Trihexyphenidyl Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Trihexyphenidyl Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Trihexyphenidyl Drug by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Trihexyphenidyl Drug by Type (2020-2031)
 Figure 55. Global Trihexyphenidyl Drug Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Trihexyphenidyl Drug by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Trihexyphenidyl Drug by Application (2020-2031)
 Figure 58. Global Trihexyphenidyl Drug Price (US$/Unit) by Application (2020-2031)
 Figure 59. Trihexyphenidyl Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture